Search results for "CLO"

showing 10 items of 9986 documents

Chemoselective, Substrate-directed Fluorination of Functionalized Cyclopentane β-Amino Acids

2016

This work describes a substrate-directed fluorination of some highly functionalized cyclopentane derivatives. The cyclic products incorporating CH2 F or CHF2 moieties in their structure have been synthesized from diexo- or diendo-norbornene β-amino acids following a stereocontrolled strategy. The synthetic study was based on an oxidative transformation of the ring carbon-carbon double bond of the norbornene β-amino acids, followed by transformation of the resulted "all cis" and "trans" diformyl intermediates by fluorination with "chemodifferentiation".

molecular diversitycyclizationDouble bondHalogenationHydrocarbons FluorinatedStereochemistryMolecular Conformationchemistry.chemical_elementCyclopentanes010402 general chemistryRing (chemistry)Crystallography X-Ray01 natural sciencesBiochemistrychemistry.chemical_compoundfluorineCyclopentaneta116Norbornenechemistry.chemical_classificationamino acidssubstituent effects010405 organic chemistryOrganic ChemistrySubstrate (chemistry)StereoisomerismGeneral Chemistry0104 chemical sciencesAmino acidchemistryFluorineOxidation-ReductionChemistry: An Asian Journal
researchProduct

Monoklonālās antivielas - mūsdienu ārstēšanas iespējas

2018

Biozāles ir viens no straujāk augošajiem farmaceitiskās rūpniecības segmentiem veselības aprūpē. Rekombinantās DNS tehnoloģijas un hibridomu tehnoloģijas progress, ir izraisījis liela mēroga proteīnu ražošanu, kuriem ir potenciāli terapeitiski pielietojumi. Kopš 1975. gada, kad pirmo reizi ziņots par monoklonālo antivielu (moAv) attīstību, pagājuši vairāk kā 40 gadi un apmēram 100 terapeitiskās moAv ir apstiprinātas kā zāles, kuras galvenokārt pielieto onkoloģisku un autoimūnu slimību terapijā. Šī pētījuma mērķis bija apzināt ārstu zināšanas par moAv un, noskaidrot ārstu pieredzi un iespējas moAv terapijas pielietošanai Latvijā. Tika veikta aptauja, kurā piedalījās 67 respondenti. Pēc aptau…

monoklonālās antivielas (moAv)audzēju terapija autoimūnas slimībasrekombinantās DNS tehnoloģijasmonoclonal antibodies (mAb)recombinant DNA technologyFarmācija
researchProduct

Theatrum niezwykłości w "Kronice wszytkiego świata" Marcina Bielskiego

2016

Praca dotyczy fenomenu niezwykłości w dawnych wiekach. Przedmiotem analizy stała się XVl-wieczna Kronika wszystkiego świata Marcina Bielskiego, która obfituje w bogaty materiał najrozmaitszych dziwów i cudowności. Struktura Kroniki Bielskiego współtworzy rodzaj theatrum, tj. kręgu wiedzy (gr. enkyklios paideia), gdzie realnie istniejące uporządkowane w przestrzeni rzeczy zostały nic tylko zinterpretowane i sklasyfikowane, ale też podporządkowane kategoriom zarówno systemu moralnego, jak i teologicznego. Wyłania się więc z encyklopedycznego dzieła Bielskiego świat pełen ładu, harmonii oraz sensu, taki, w którym swoje miejsce i znaczenie zyskuje każda nawet najbardziej nietypowa i dziwaczna r…

monstrumzroślaktheatrumhuman racescosmosdziwcuriosumencyklopediarasy ludzkiewonderkosmosmonsterconjoined twinsdziwnyencyclopaedia
researchProduct

Quelques observations récentes sur des sites de l'Antiquité tardive à Autun (2001-2008)

2011

This article describes the result of ten or so fairly limited preventive archaeology operations (surveillance of works, diagnostics not followed up with excavations) carried out over the last ten years that have nonetheless finalised knowledge of several deposits from Late Antiquity in Autun located intra muros but also outside the walls. The works have enabled us to renew our knowledge of the reduced enclosure and of three Late Antiquity necropolises, to discover the remains of a lime kiln from the end of the 4th century at the centre of a public zone (perhaps the forum), and lastly to point up the difficulties of interpretation of an occupation of two zones from the end of the 4th century…

monumental zonelime kiln[SHS.ARCHEO] Humanities and Social Sciences/Archaeology and Prehistory[SHS.ARCHEO]Humanities and Social Sciences/Archaeology and PrehistoryReduced enclosuredomusîlot monumental[ SHS.ARCHEO ] Humanities and Social Sciences/Archaeology and PrehistoryEnceinte réduiteforumatelier de chaufourniernécropolenecropolis
researchProduct

Comparison of the acute effects of anti-TNF-alpha drugs on a uveitis experimental model.

2010

To compare histopathological and biochemical effects of the anti-TNF-alpha drugs adalimumab and infliximab in a uveitis experimental model.Histopathological evaluation was performed 24 h after endotoxin (200 microg into the footpad) and drug administration, as well as biochemical analysis of oxidative stress-related markers in the aqueous humor.Severe inflammation was found in rat anterior chamber of the eye 24 h after endotoxin. Only infliximab administration partially prevented the endotoxin-induced disruption of the blood-aqueous barrier, as well as the increase in Rantes and MCP-1 concentration in aqueous humor. Both drugs ameliorated the histopathological score after endotoxin. Biochem…

musculoskeletal diseasesAcute effectsMaleBlood-Aqueous BarrierTime FactorsAnti-Inflammatory AgentsInflammationmedicine.disease_causeAntibodies Monoclonal HumanizedAqueous HumorUveitisAdalimumabImmunology and AllergyMedicineAnimalsskin and connective tissue diseasesCells Culturedbiologybusiness.industryTumor Necrosis Factor-alphaAdalimumabAntibodies Monoclonalmedicine.diseaseInfliximabInfliximabRatsOphthalmologyDisease Models AnimalOxidative StressTreatment OutcomeRats Inbred LewImmunologyMonoclonalbiology.proteinAntibodymedicine.symptombusinessOxidative stressUveitismedicine.drugOcular immunology and inflammation
researchProduct

Adalimumab in active ulcerative colitis: A “real-life” observational study

2013

Abstract Background and aims The effectiveness of adalimumab in the treatment of ulcerative colitis is under debate. Although controlled trials have shown that adalimumab is significantly better than placebo, the absolute clinical benefit is modest. We report data on the effectiveness of adalimumab in a cohort of ulcerative colitis patients treated in 22 Italian centres. Methods All patients with active disease treated with adalimumab were retrospectively reviewed. Co-primary endpoints were clinical remission at weeks 4, 12, 24 and 54. Secondary endpoints were sustained clinical remission, steroid discontinuation, endoscopic remission and need for colectomy. Results Eighty-eight patients we…

musculoskeletal diseasesAdultMaleAdalimumab “Real-life” study Ulcerative colitismedicine.medical_specialtymedicine.medical_treatmentIBDAnti-Inflammatory AgentsAdalimumab; “Real-life” study; Ulcerative colitisAntibodies Monoclonal HumanizedPlaceboCohort StudiesYoung AdultRefractoryAdrenal Cortex HormonesInternal medicineAdalimumabmedicineHumansskin and connective tissue diseases“Real-life” studyRetrospective StudiesColectomySettore MED/12 - GastroenterologiaHepatologybusiness.industryRemission InductionSettore MED/09 - MEDICINA INTERNAGastroenterologyAdalimumabmedicine.diseaseUlcerative colitishumanitiesInfliximabSurgeryDiscontinuationTreatment OutcomeUlcerative colitisCohortColitis UlcerativeDrug Therapy CombinationFemalebusinessmedicine.drug
researchProduct

HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis.

1993

Ankylosing spondylitis and seronegative spondylarthropathies such as Reiter's syndrome and reactive arthritis are strongly associated with HLA-B27. However, the mechanisms by which HLA-B27 is involved in disease susceptibility and pathogenesis are unknown. If the disease association is a consequence of HLA-B27's physiological function in antigen presentation, the disease should be mediated by cytotoxic T lymphocytes (CTLs) that recognise bacterial or self peptides presented by HLA-B27. Proof of this arthritogenic peptide model requires isolation of B27-restricted CD8 T cells from arthritic joints of patients with spondylarthropathies. An important question is whether "arthritogenic" bacteri…

musculoskeletal diseasesAdultMaleSalmonella typhimuriumYersinia InfectionsCD8 AntigensAntigen presentationArthritisArthritis ReactiveSynovial FluidmedicineCytotoxic T cellHumansReactive arthritisSpondylitis Ankylosingskin and connective tissue diseasesSpondylarthropathiesHLA-B27 AntigenYersinia enterocoliticaAnkylosing spondylitisHLA-B27business.industryGeneral MedicineChlamydia Infectionsmedicine.diseaseClone CellsImmunologySalmonella InfectionsbusinessCD8T-Lymphocytes CytotoxicLancet (London, England)
researchProduct

Clonal heterogeneity of the growth and invasive response of a human breast carcinoma cell line to parathyroid hormone-related peptide fragments

1997

It has been previously reported that 8701-BC cells, derived from a primary carcinoma of the breast, constitutively express parathyroid hormone (PTH)-related peptide (PTHrP) and PTH/PTHrP receptor (PTH/PTHrP-R) genes, that N-terminal, mid-regional and C-terminal immunoreactive PTHrP can be found in cell conditioned medium and, furthermore, that exogenously added PTHrP (1-34), (67-86) and, to a minor extent, (107-139) are anti-mitogenic but promote Matrigel invasion by this cell line. It has also been reported that PTHrP gene expression is selectively switched on in those 8701-BC clonal lines endowed with a higher proliferation rate and invasive ability in vitro. Here we have first examined t…

musculoskeletal diseasesCancer Researchmedicine.medical_specialtyPopulationParathyroid hormoneBreast NeoplasmsBiologyInternal medicineGene expressionTumor Cells CulturedmedicineHumansNeoplasm Invasivenesseducationeducation.field_of_studyParathyroid hormone-related proteinCell growthParathyroid hormone receptorParathyroid Hormone-Related ProteinProteinsGeneral Medicinemusculoskeletal systemMolecular biologyPeptide FragmentsNeoplasm ProteinsEndocrinologyParathyroid HormoneCell cultureFemaleClone (B-cell biology)Cell Divisionhormones hormone substitutes and hormone antagonistsCarcinogenesis
researchProduct

Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease

2011

14 páginas, 8 figuras, 1 tabla.-- et al.

musculoskeletal diseasesGenetically modified mouseMedicinaNF-E2-Related Factor 2PhysiologyChemokine CXCL1Clinical BiochemistryNitric Oxide Synthase Type IIArthritisMice Transgenicmedicine.disease_causeenvironment and public healthBiochemistryNrf2MicemedicineAnimalsMolecular BiologyGeneral Environmental SciencebiologyInterleukin-6Effectorbusiness.industryArthritisInflammation and degenerationCell Biologyrespiratory systemmedicine.diseaseArthritis ExperimentalInfection and autoimmunity Auto-immunity transplantation and immunotherapy [NCMLS 1]Disease Models AnimalOxidative StressEicosanoidCyclooxygenase 2Rheumatoid arthritisTumor Necrosis FactorsImmunologyOsteocalcinbiology.proteinGeneral Earth and Planetary SciencesJointsTumor necrosis factor alphaImmune Regulation Auto-immunity transplantation and immunotherapy [NCMLS 2]businessOxidation-ReductionHeme Oxygenase-1Oxidative stress
researchProduct

COX-2 expression in chondrosarcoma: A role for celecoxib treatment?

2010

Chondrosarcomas are resistant to conventional chemo- and radiotherapy. A subset of chondrosarcomas arises secondarily in the benign tumour syndromes enchondromatosis (EC) and multiple osteochondromas (MO), and prevention of tumour development would greatly improve prognosis. We therefore investigated the effect of selective COX-2 inhibition on chondrosarcoma growth. COX-2 expression was studied in central- and peripheral cartilaginous tumours. The effect of COX-2 inhibition was assessed in four high-grade chondrosarcoma cell lines using celecoxib and NS-398 treatment. COX-2 activity (prostaglandin E-2 (PGE(2)) ELISA) and cell viability were measured. The (prophylactic) effect of celecoxib o…

musculoskeletal diseasesMaleCancer ResearchPathologymedicine.medical_specialtyCell Survivalmedicine.medical_treatmentChondrosarcomaDrug Evaluation PreclinicalMice NudeAntineoplastic AgentsBone NeoplasmsMiceIn vivomedicineTumor Cells CulturedAnimalsHumansViability assaySulfonamidesCyclooxygenase 2 Inhibitorsbusiness.industryCartilagemedicine.diseaseXenograft Model Antitumor AssaysRadiation therapyDisease Models Animalmedicine.anatomical_structureOncologyBone tumours Chondrosarcoma COX-2 inhibition Therapy Xenograft familial adenomatous polyposis cell-line cyclooxygenase-2 inhibitor trial tumors establishment emphasis origin boneCell cultureCelecoxibCyclooxygenase 2CelecoxibPyrazolesChondrosarcomabusinessmedicine.drugProstaglandin E
researchProduct